Mark Hadden

发表

Inhibition Of Proliferation And Signalling Mechanisms In Human Lymphocytes By Fluvastatin

A. Jardine, D. Hillyard, A. Cameron, 2002, Clinical and experimental pharmacology & physiology.

Synthesis of the heterocyclic core of martinelline and martinellic acid

Mark Hadden, M. Nieuwenhuyzen, P. Stevenson, 2006 .

Regioselective synthesis of pyrroloquinolines — Approaches to Martinelline

Mark Hadden, P. Stevenson, 1999 .

Synthesis of the heterocyclic core of the alkaloids martinelline and martinellic acid

Mark Hadden, M. Nieuwenhuyzen, P. Stevenson, 2001 .

Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties.

Chong-Hwan Chang, P. Lam, D. Cheney, 2008, Bioorganic & medicinal chemistry letters.

Facile Synthesis of Methyl 2-amino-3-(2-methyl-3-quinolyl)propanoate

Mark Hadden, P. Stevenson, 1998 .

5-(pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl)indazoles as MCH-1 antagonists.

Mark Hadden, S. Cheetham, Y. Khmelnitsky, 2010, Bioorganic & medicinal chemistry letters.

Aza-annulation of enaminones with crotonyl chloride — Formal reversal of regioselectivity

Mark Hadden, P. Stevenson, James P. Murphy, 1997 .

Aza-annulation of enaminones with itaconic anhydride: kinetic preference for exocyclic enamide products

Mark Hadden, M. Nieuwenhuyzen, P. Stevenson, 1998 .

Synthesis and reactivity of hexahydropyrroloquinolines

Mark Hadden, M. Nieuwenhuyzen, P. Stevenson, 2001 .

Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites

O. Arancio, Valérie Campagna-Slater, D. Weaver, 2022, Alzheimer's & dementia.

2,3-Diaminopyrazines as Rho kinase inhibitors.

N. Sharif, H. Decornez, Mark Hadden, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.

M. Reitman, J. Metzger, Mark Hadden, 2010, Bioorganic & medicinal chemistry letters.

Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.

M. Reitman, J. Metzger, Mark Hadden, 2010, Bioorganic & medicinal chemistry letters.

Tetrahydrocarboline analogs as MCH-1 antagonists.

Mark Hadden, S. Cheetham, Y. Khmelnitsky, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity.

Mark Hadden, S. Cheetham, Y. Khmelnitsky, 2010, Bioorganic & medicinal chemistry letters.

Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.

J. Metzger, Mark Hadden, O. Palyha, 2010, Bioorganic & Medicinal Chemistry Letters.

Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.

M. Reitman, J. Metzger, Mark Hadden, 2010, Bioorganic & medicinal chemistry letters.